ペプチド療法のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Peptide Therapy Market Insights, Forecast to 2028

• レポートコード：QY2207E10457 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のペプチド療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にペプチド療法の世界市場のxxx％を占める「非経口投与経路」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「癌」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のペプチド療法の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのペプチド療法市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのペプチド療法市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ペプチド療法のグローバル主要メーカーには、Eli Lilly、AstraZeneca、Merck、Ipsen、Novo Nordisk、Teva Pharmaceutical Industries、Abbott Laboratories、Sanofi、J & J、Novartis、Takeda、Ferring、AbbVie、Heinis、Hemmo、Emcure Pharmaceutical、Cipla、Gland Pharma、Troikaa Pharmaceuticals、Biological Eなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ペプチド療法市場は、種類と用途によって区分されます。世界のペプチド療法市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 非経口投与経路、粘膜投与経路、経口投与経路、経皮投与経路 【用途別セグメント】 癌、循環器疾患、消化器疾患、代謝性疾患、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ペプチド療法製品概要 - 種類別市場（非経口投与経路、粘膜投与経路、経口投与経路、経皮投与経路） - 用途別市場（癌、循環器疾患、消化器疾患、代謝性疾患、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のペプチド療法販売量予測2017-2028 - 世界のペプチド療法売上予測2017-2028 - ペプチド療法の地域別販売量 - ペプチド療法の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ペプチド療法販売量 - 主要メーカー別ペプチド療法売上 - 主要メーカー別ペプチド療法価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（非経口投与経路、粘膜投与経路、経口投与経路、経皮投与経路） - ペプチド療法の種類別販売量 - ペプチド療法の種類別売上 - ペプチド療法の種類別価格 ・用途別市場規模（癌、循環器疾患、消化器疾患、代謝性疾患、その他） - ペプチド療法の用途別販売量 - ペプチド療法の用途別売上 - ペプチド療法の用途別価格 ・北米市場 - 北米のペプチド療法市場規模（種類別、用途別） - 主要国別のペプチド療法市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのペプチド療法市場規模（種類別、用途別） - 主要国別のペプチド療法市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のペプチド療法市場規模（種類別、用途別） - 主要国別のペプチド療法市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のペプチド療法市場規模（種類別、用途別） - 主要国別のペプチド療法市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのペプチド療法市場規模（種類別、用途別） - 主要国別のペプチド療法市場規模（トルコ、サウジアラビア） ・企業情報 Eli Lilly、AstraZeneca、Merck、Ipsen、Novo Nordisk、Teva Pharmaceutical Industries、Abbott Laboratories、Sanofi、J & J、Novartis、Takeda、Ferring、AbbVie、Heinis、Hemmo、Emcure Pharmaceutical、Cipla、Gland Pharma、Troikaa Pharmaceuticals、Biological E ・産業チェーン及び販売チャネル分析 - ペプチド療法の産業チェーン分析 - ペプチド療法の原材料 - ペプチド療法の生産プロセス - ペプチド療法の販売及びマーケティング - ペプチド療法の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ペプチド療法の産業動向 - ペプチド療法のマーケットドライバー - ペプチド療法の課題 - ペプチド療法の阻害要因 ・主な調査結果

Peptide therapy refers to restoring the amount of peptides to stimulate the cellular regeneration system in the body, and can be an excellent complement to small molecule and biotherapeutics as a treatment option under certain conditions. The most common uses of peptide therapy are to help build muscle and reduce fat, increase energy, improve sexual function, and reduce gastrointestinal and musculoskeletal inflammation. The most common prescription peptide combinations naturally boost growth hormone for better recovery. Peptides were initially used only for diagnostics and hormone therapy; however, as technology has advanced, they are now also widely used to treat cancer and chronic metabolic diseases. Peptides are also used in cosmeceutical operations to slow down the skin’s aging process.
Market Analysis and Insights: Global Peptide Therapy Market
Due to the COVID-19 pandemic, the global Peptide Therapy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Parenteral Route of Administration accounting for % of the Peptide Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cancer segment is altered to an % CAGR throughout this forecast period.
China Peptide Therapy market size is valued at US$ million in 2021, while the US and Europe Peptide Therapy are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Peptide Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Peptide Therapy include Eli Lilly, AstraZeneca, Merck, Ipsen, Novo Nordisk, Teva Pharmaceutical Industries, Abbott Laboratories, Sanofi and J & J, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Peptide Therapy Scope and Segment
Peptide Therapy market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Peptide Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Parenteral Route of Administration
Mucosal Route of Administration
Oral Route of Administration
Transdermal Route of Administration
Segment by Application
Cancer
Cardiovascular Diseases
Gastrointestinal Disorders
Metabolic Disorders
Others
By Company
Eli Lilly
AstraZeneca
Merck
Ipsen
Novo Nordisk
Teva Pharmaceutical Industries
Abbott Laboratories
Sanofi
J & J
Novartis
Takeda
Ferring
AbbVie
Heinis
Hemmo
Emcure Pharmaceutical
Cipla
Gland Pharma
Troikaa Pharmaceuticals
Biological E
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Peptide Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Peptide Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Parenteral Route of Administration
1.2.3 Mucosal Route of Administration
1.2.4 Oral Route of Administration
1.2.5 Transdermal Route of Administration
1.3 Market by Application
1.3.1 Global Peptide Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Gastrointestinal Disorders
1.3.5 Metabolic Disorders
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Peptide Therapy Sales Estimates and Forecasts 2017-2028
2.2 Global Peptide Therapy Revenue Estimates and Forecasts 2017-2028
2.3 Global Peptide Therapy Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Peptide Therapy Sales by Region
2.4.1 Global Peptide Therapy Sales by Region (2017-2022)
2.4.2 Global Sales Peptide Therapy by Region (2023-2028)
2.5 Global Peptide Therapy Revenue by Region
2.5.1 Global Peptide Therapy Revenue by Region (2017-2022)
2.5.2 Global Peptide Therapy Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Peptide Therapy Sales by Manufacturers
3.1.1 Global Top Peptide Therapy Manufacturers by Sales (2017-2022)
3.1.2 Global Peptide Therapy Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Peptide Therapy in 2021
3.2 Global Peptide Therapy Revenue by Manufacturers
3.2.1 Global Peptide Therapy Revenue by Manufacturers (2017-2022)
3.2.2 Global Peptide Therapy Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Peptide Therapy Revenue in 2021
3.3 Global Peptide Therapy Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Peptide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Peptide Therapy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Peptide Therapy Sales by Type
4.1.1 Global Peptide Therapy Historical Sales by Type (2017-2022)
4.1.2 Global Peptide Therapy Forecasted Sales by Type (2023-2028)
4.1.3 Global Peptide Therapy Sales Market Share by Type (2017-2028)
4.2 Global Peptide Therapy Revenue by Type
4.2.1 Global Peptide Therapy Historical Revenue by Type (2017-2022)
4.2.2 Global Peptide Therapy Forecasted Revenue by Type (2023-2028)
4.2.3 Global Peptide Therapy Revenue Market Share by Type (2017-2028)
4.3 Global Peptide Therapy Price by Type
4.3.1 Global Peptide Therapy Price by Type (2017-2022)
4.3.2 Global Peptide Therapy Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Peptide Therapy Sales by Application
5.1.1 Global Peptide Therapy Historical Sales by Application (2017-2022)
5.1.2 Global Peptide Therapy Forecasted Sales by Application (2023-2028)
5.1.3 Global Peptide Therapy Sales Market Share by Application (2017-2028)
5.2 Global Peptide Therapy Revenue by Application
5.2.1 Global Peptide Therapy Historical Revenue by Application (2017-2022)
5.2.2 Global Peptide Therapy Forecasted Revenue by Application (2023-2028)
5.2.3 Global Peptide Therapy Revenue Market Share by Application (2017-2028)
5.3 Global Peptide Therapy Price by Application
5.3.1 Global Peptide Therapy Price by Application (2017-2022)
5.3.2 Global Peptide Therapy Price Forecast by Application (2023-2028)
6 North America
6.1 North America Peptide Therapy Market Size by Type
6.1.1 North America Peptide Therapy Sales by Type (2017-2028)
6.1.2 North America Peptide Therapy Revenue by Type (2017-2028)
6.2 North America Peptide Therapy Market Size by Application
6.2.1 North America Peptide Therapy Sales by Application (2017-2028)
6.2.2 North America Peptide Therapy Revenue by Application (2017-2028)
6.3 North America Peptide Therapy Market Size by Country
6.3.1 North America Peptide Therapy Sales by Country (2017-2028)
6.3.2 North America Peptide Therapy Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Peptide Therapy Market Size by Type
7.1.1 Europe Peptide Therapy Sales by Type (2017-2028)
7.1.2 Europe Peptide Therapy Revenue by Type (2017-2028)
7.2 Europe Peptide Therapy Market Size by Application
7.2.1 Europe Peptide Therapy Sales by Application (2017-2028)
7.2.2 Europe Peptide Therapy Revenue by Application (2017-2028)
7.3 Europe Peptide Therapy Market Size by Country
7.3.1 Europe Peptide Therapy Sales by Country (2017-2028)
7.3.2 Europe Peptide Therapy Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Peptide Therapy Market Size by Type
8.1.1 Asia Pacific Peptide Therapy Sales by Type (2017-2028)
8.1.2 Asia Pacific Peptide Therapy Revenue by Type (2017-2028)
8.2 Asia Pacific Peptide Therapy Market Size by Application
8.2.1 Asia Pacific Peptide Therapy Sales by Application (2017-2028)
8.2.2 Asia Pacific Peptide Therapy Revenue by Application (2017-2028)
8.3 Asia Pacific Peptide Therapy Market Size by Region
8.3.1 Asia Pacific Peptide Therapy Sales by Region (2017-2028)
8.3.2 Asia Pacific Peptide Therapy Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Peptide Therapy Market Size by Type
9.1.1 Latin America Peptide Therapy Sales by Type (2017-2028)
9.1.2 Latin America Peptide Therapy Revenue by Type (2017-2028)
9.2 Latin America Peptide Therapy Market Size by Application
9.2.1 Latin America Peptide Therapy Sales by Application (2017-2028)
9.2.2 Latin America Peptide Therapy Revenue by Application (2017-2028)
9.3 Latin America Peptide Therapy Market Size by Country
9.3.1 Latin America Peptide Therapy Sales by Country (2017-2028)
9.3.2 Latin America Peptide Therapy Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Peptide Therapy Market Size by Type
10.1.1 Middle East and Africa Peptide Therapy Sales by Type (2017-2028)
10.1.2 Middle East and Africa Peptide Therapy Revenue by Type (2017-2028)
10.2 Middle East and Africa Peptide Therapy Market Size by Application
10.2.1 Middle East and Africa Peptide Therapy Sales by Application (2017-2028)
10.2.2 Middle East and Africa Peptide Therapy Revenue by Application (2017-2028)
10.3 Middle East and Africa Peptide Therapy Market Size by Country
10.3.1 Middle East and Africa Peptide Therapy Sales by Country (2017-2028)
10.3.2 Middle East and Africa Peptide Therapy Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Eli Lilly Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Ipsen
11.4.1 Ipsen Corporation Information
11.4.2 Ipsen Overview
11.4.3 Ipsen Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ipsen Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ipsen Recent Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Corporation Information
11.5.2 Novo Nordisk Overview
11.5.3 Novo Nordisk Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novo Nordisk Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novo Nordisk Recent Developments
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Corporation Information
11.6.2 Teva Pharmaceutical Industries Overview
11.6.3 Teva Pharmaceutical Industries Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Pharmaceutical Industries Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharmaceutical Industries Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Corporation Information
11.7.2 Abbott Laboratories Overview
11.7.3 Abbott Laboratories Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Abbott Laboratories Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Laboratories Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 J & J
11.9.1 J & J Corporation Information
11.9.2 J & J Overview
11.9.3 J & J Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 J & J Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 J & J Recent Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Overview
11.10.3 Novartis Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novartis Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis Recent Developments
11.11 Takeda
11.11.1 Takeda Corporation Information
11.11.2 Takeda Overview
11.11.3 Takeda Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Takeda Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Takeda Recent Developments
11.12 Ferring
11.12.1 Ferring Corporation Information
11.12.2 Ferring Overview
11.12.3 Ferring Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Ferring Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Ferring Recent Developments
11.13 AbbVie
11.13.1 AbbVie Corporation Information
11.13.2 AbbVie Overview
11.13.3 AbbVie Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 AbbVie Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 AbbVie Recent Developments
11.14 Heinis
11.14.1 Heinis Corporation Information
11.14.2 Heinis Overview
11.14.3 Heinis Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Heinis Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Heinis Recent Developments
11.15 Hemmo
11.15.1 Hemmo Corporation Information
11.15.2 Hemmo Overview
11.15.3 Hemmo Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Hemmo Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Hemmo Recent Developments
11.16 Emcure Pharmaceutical
11.16.1 Emcure Pharmaceutical Corporation Information
11.16.2 Emcure Pharmaceutical Overview
11.16.3 Emcure Pharmaceutical Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Emcure Pharmaceutical Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Emcure Pharmaceutical Recent Developments
11.17 Cipla
11.17.1 Cipla Corporation Information
11.17.2 Cipla Overview
11.17.3 Cipla Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Cipla Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Cipla Recent Developments
11.18 Gland Pharma
11.18.1 Gland Pharma Corporation Information
11.18.2 Gland Pharma Overview
11.18.3 Gland Pharma Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Gland Pharma Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Gland Pharma Recent Developments
11.19 Troikaa Pharmaceuticals
11.19.1 Troikaa Pharmaceuticals Corporation Information
11.19.2 Troikaa Pharmaceuticals Overview
11.19.3 Troikaa Pharmaceuticals Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Troikaa Pharmaceuticals Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Troikaa Pharmaceuticals Recent Developments
11.20 Biological E
11.20.1 Biological E Corporation Information
11.20.2 Biological E Overview
11.20.3 Biological E Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Biological E Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Biological E Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Peptide Therapy Industry Chain Analysis
12.2 Peptide Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Peptide Therapy Production Mode & Process
12.4 Peptide Therapy Sales and Marketing
12.4.1 Peptide Therapy Sales Channels
12.4.2 Peptide Therapy Distributors
12.5 Peptide Therapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Peptide Therapy Industry Trends
13.2 Peptide Therapy Market Drivers
13.3 Peptide Therapy Market Challenges
13.4 Peptide Therapy Market Restraints
14 Key Findings in The Global Peptide Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Peptide Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Parenteral Route of Administration
Table 3. Major Manufacturers of Mucosal Route of Administration
Table 4. Major Manufacturers of Oral Route of Administration
Table 5. Major Manufacturers of Transdermal Route of Administration
Table 6. Global Peptide Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Peptide Therapy Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Peptide Therapy Sales by Region (2017-2022) & (K Units)
Table 9. Global Peptide Therapy Sales Market Share by Region (2017-2022)
Table 10. Global Peptide Therapy Sales by Region (2023-2028) & (K Units)
Table 11. Global Peptide Therapy Sales Market Share by Region (2023-2028)
Table 12. Global Peptide Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Peptide Therapy Revenue Market Share by Region (2017-2022)
Table 14. Global Peptide Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Peptide Therapy Revenue Market Share by Region (2023-2028)
Table 16. Global Peptide Therapy Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Peptide Therapy Sales Share by Manufacturers (2017-2022)
Table 18. Global Peptide Therapy Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Peptide Therapy Revenue Share by Manufacturers (2017-2022)
Table 20. Peptide Therapy Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Peptide Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Peptide Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapy as of 2021)
Table 23. Peptide Therapy Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Peptide Therapy Product Offered
Table 25. Date of Manufacturers Enter into Peptide Therapy Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Peptide Therapy Sales by Type (2017-2022) & (K Units)
Table 28. Global Peptide Therapy Sales by Type (2023-2028) & (K Units)
Table 29. Global Peptide Therapy Sales Share by Type (2017-2022)
Table 30. Global Peptide Therapy Sales Share by Type (2023-2028)
Table 31. Global Peptide Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Peptide Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Peptide Therapy Revenue Share by Type (2017-2022)
Table 34. Global Peptide Therapy Revenue Share by Type (2023-2028)
Table 35. Peptide Therapy Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Peptide Therapy Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Peptide Therapy Sales by Application (2017-2022) & (K Units)
Table 38. Global Peptide Therapy Sales by Application (2023-2028) & (K Units)
Table 39. Global Peptide Therapy Sales Share by Application (2017-2022)
Table 40. Global Peptide Therapy Sales Share by Application (2023-2028)
Table 41. Global Peptide Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Peptide Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Peptide Therapy Revenue Share by Application (2017-2022)
Table 44. Global Peptide Therapy Revenue Share by Application (2023-2028)
Table 45. Peptide Therapy Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Peptide Therapy Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Peptide Therapy Sales by Type (2017-2022) & (K Units)
Table 48. North America Peptide Therapy Sales by Type (2023-2028) & (K Units)
Table 49. North America Peptide Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Peptide Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Peptide Therapy Sales by Application (2017-2022) & (K Units)
Table 52. North America Peptide Therapy Sales by Application (2023-2028) & (K Units)
Table 53. North America Peptide Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Peptide Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Peptide Therapy Sales by Country (2017-2022) & (K Units)
Table 56. North America Peptide Therapy Sales by Country (2023-2028) & (K Units)
Table 57. North America Peptide Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Peptide Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Peptide Therapy Sales by Type (2017-2022) & (K Units)
Table 60. Europe Peptide Therapy Sales by Type (2023-2028) & (K Units)
Table 61. Europe Peptide Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Peptide Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Peptide Therapy Sales by Application (2017-2022) & (K Units)
Table 64. Europe Peptide Therapy Sales by Application (2023-2028) & (K Units)
Table 65. Europe Peptide Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Peptide Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Peptide Therapy Sales by Country (2017-2022) & (K Units)
Table 68. Europe Peptide Therapy Sales by Country (2023-2028) & (K Units)
Table 69. Europe Peptide Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Peptide Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Peptide Therapy Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Peptide Therapy Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Peptide Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Peptide Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Peptide Therapy Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Peptide Therapy Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Peptide Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Peptide Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Peptide Therapy Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Peptide Therapy Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Peptide Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Peptide Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Peptide Therapy Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Peptide Therapy Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Peptide Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Peptide Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Peptide Therapy Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Peptide Therapy Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Peptide Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Peptide Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Peptide Therapy Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Peptide Therapy Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Peptide Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Peptide Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Peptide Therapy Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Peptide Therapy Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Peptide Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Peptide Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Peptide Therapy Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Peptide Therapy Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Peptide Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Peptide Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Peptide Therapy Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Peptide Therapy Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Peptide Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Peptide Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 107. Eli Lilly Corporation Information
Table 108. Eli Lilly Description and Major Businesses
Table 109. Eli Lilly Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Eli Lilly Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Eli Lilly Recent Developments
Table 112. AstraZeneca Corporation Information
Table 113. AstraZeneca Description and Major Businesses
Table 114. AstraZeneca Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. AstraZeneca Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. AstraZeneca Recent Developments
Table 117. Merck Corporation Information
Table 118. Merck Description and Major Businesses
Table 119. Merck Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Merck Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Merck Recent Developments
Table 122. Ipsen Corporation Information
Table 123. Ipsen Description and Major Businesses
Table 124. Ipsen Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Ipsen Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Ipsen Recent Developments
Table 127. Novo Nordisk Corporation Information
Table 128. Novo Nordisk Description and Major Businesses
Table 129. Novo Nordisk Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Novo Nordisk Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Novo Nordisk Recent Developments
Table 132. Teva Pharmaceutical Industries Corporation Information
Table 133. Teva Pharmaceutical Industries Description and Major Businesses
Table 134. Teva Pharmaceutical Industries Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Teva Pharmaceutical Industries Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Teva Pharmaceutical Industries Recent Developments
Table 137. Abbott Laboratories Corporation Information
Table 138. Abbott Laboratories Description and Major Businesses
Table 139. Abbott Laboratories Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Abbott Laboratories Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Abbott Laboratories Recent Developments
Table 142. Sanofi Corporation Information
Table 143. Sanofi Description and Major Businesses
Table 144. Sanofi Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Sanofi Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Sanofi Recent Developments
Table 147. J & J Corporation Information
Table 148. J & J Description and Major Businesses
Table 149. J & J Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. J & J Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. J & J Recent Developments
Table 152. Novartis Corporation Information
Table 153. Novartis Description and Major Businesses
Table 154. Novartis Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Novartis Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Novartis Recent Developments
Table 157. Takeda Corporation Information
Table 158. Takeda Description and Major Businesses
Table 159. Takeda Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Takeda Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Takeda Recent Developments
Table 162. Ferring Corporation Information
Table 163. Ferring Description and Major Businesses
Table 164. Ferring Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. Ferring Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Ferring Recent Developments
Table 167. AbbVie Corporation Information
Table 168. AbbVie Description and Major Businesses
Table 169. AbbVie Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 170. AbbVie Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. AbbVie Recent Developments
Table 172. Heinis Corporation Information
Table 173. Heinis Description and Major Businesses
Table 174. Heinis Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 175. Heinis Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Heinis Recent Developments
Table 177. Hemmo Corporation Information
Table 178. Hemmo Description and Major Businesses
Table 179. Hemmo Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 180. Hemmo Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Hemmo Recent Developments
Table 182. Emcure Pharmaceutical Corporation Information
Table 183. Emcure Pharmaceutical Description and Major Businesses
Table 184. Emcure Pharmaceutical Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 185. Emcure Pharmaceutical Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Emcure Pharmaceutical Recent Developments
Table 187. Cipla Corporation Information
Table 188. Cipla Description and Major Businesses
Table 189. Cipla Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 190. Cipla Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Cipla Recent Developments
Table 192. Gland Pharma Corporation Information
Table 193. Gland Pharma Description and Major Businesses
Table 194. Gland Pharma Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 195. Gland Pharma Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Gland Pharma Recent Developments
Table 197. Troikaa Pharmaceuticals Corporation Information
Table 198. Troikaa Pharmaceuticals Description and Major Businesses
Table 199. Troikaa Pharmaceuticals Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 200. Troikaa Pharmaceuticals Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Troikaa Pharmaceuticals Recent Developments
Table 202. Biological E Corporation Information
Table 203. Biological E Description and Major Businesses
Table 204. Biological E Peptide Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 205. Biological E Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Biological E Recent Developments
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. Peptide Therapy Distributors List
Table 210. Peptide Therapy Customers List
Table 211. Peptide Therapy Market Trends
Table 212. Peptide Therapy Market Drivers
Table 213. Peptide Therapy Market Challenges
Table 214. Peptide Therapy Market Restraints
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Therapy Product Picture
Figure 3. Global Peptide Therapy Market Share by Type in 2021 & 2028
Figure 3. Parenteral Route of Administration Product Picture
Figure 4. Mucosal Route of Administration Product Picture
Figure 5. Oral Route of Administration Product Picture
Figure 6. Transdermal Route of Administration Product Picture
Figure 7. Global Peptide Therapy Market Share by Application in 2021 & 2028
Figure 8. Cancer
Figure 9. Cardiovascular Diseases
Figure 10. Gastrointestinal Disorders
Figure 11. Metabolic Disorders
Figure 12. Others
Figure 13. Peptide Therapy Report Years Considered
Figure 14. Global Peptide Therapy Sales 2017-2028 (K Units)
Figure 15. Global Peptide Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Peptide Therapy Revenue 2017-2028 (US$ Million)
Figure 17. Global Peptide Therapy Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Peptide Therapy Sales Market Share by Region (2017-2022)
Figure 19. Global Peptide Therapy Sales Market Share by Region (2023-2028)
Figure 20. North America Peptide Therapy Sales YoY (2017-2028) & (K Units)
Figure 21. North America Peptide Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Peptide Therapy Sales YoY (2017-2028) & (K Units)
Figure 23. Europe Peptide Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Peptide Therapy Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific Peptide Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Peptide Therapy Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America Peptide Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Peptide Therapy Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa Peptide Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Peptide Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Peptide Therapy in the World: Market Share by Peptide Therapy Revenue in 2021
Figure 32. Global Peptide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Peptide Therapy Sales Market Share by Type (2017-2028)
Figure 34. Global Peptide Therapy Revenue Market Share by Type (2017-2028)
Figure 35. Global Peptide Therapy Sales Market Share by Application (2017-2028)
Figure 36. Global Peptide Therapy Revenue Market Share by Application (2017-2028)
Figure 37. North America Peptide Therapy Sales Market Share by Type (2017-2028)
Figure 38. North America Peptide Therapy Revenue Market Share by Type (2017-2028)
Figure 39. North America Peptide Therapy Sales Market Share by Application (2017-2028)
Figure 40. North America Peptide Therapy Revenue Market Share by Application (2017-2028)
Figure 41. North America Peptide Therapy Sales Share by Country (2017-2028)
Figure 42. North America Peptide Therapy Revenue Share by Country (2017-2028)
Figure 43. United States Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Peptide Therapy Sales Market Share by Type (2017-2028)
Figure 46. Europe Peptide Therapy Revenue Market Share by Type (2017-2028)
Figure 47. Europe Peptide Therapy Sales Market Share by Application (2017-2028)
Figure 48. Europe Peptide Therapy Revenue Market Share by Application (2017-2028)
Figure 49. Europe Peptide Therapy Sales Share by Country (2017-2028)
Figure 50. Europe Peptide Therapy Revenue Share by Country (2017-2028)
Figure 51. Germany Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 52. France Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Peptide Therapy Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Peptide Therapy Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Peptide Therapy Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Peptide Therapy Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Peptide Therapy Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Peptide Therapy Revenue Share by Region (2017-2028)
Figure 62. China Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 65. India Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 67. China Taiwan Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Peptide Therapy Sales Market Share by Type (2017-2028)
Figure 72. Latin America Peptide Therapy Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Peptide Therapy Sales Market Share by Application (2017-2028)
Figure 74. Latin America Peptide Therapy Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Peptide Therapy Sales Share by Country (2017-2028)
Figure 76. Latin America Peptide Therapy Revenue Share by Country (2017-2028)
Figure 77. Mexico Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 80. Colombia Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Peptide Therapy Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Peptide Therapy Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Peptide Therapy Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Peptide Therapy Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Peptide Therapy Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Peptide Therapy Revenue Share by Country (2017-2028)
Figure 87. Turkey Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 89. UAE Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 90. Peptide Therapy Value Chain
Figure 91. Peptide Therapy Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed

---